Andrew Fisher, General Counsel at Verona Pharma plc (VRNA), sold 80,000 shares at $8.57 ($686K) on 2025-05-15, disclosed to the SEC on 2025-05-16.
Scheduled sale ($686k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRNA | SELL | 2025-05-01 | $468K | — | Filing → |